Back to 
Invesco Ltd.
Invesco Ltd.
XERS
Showing 8 of 19 quarters
Position history for Invesco Ltd.'s holdings in Xeris Biopharma Holdings, Inc.
Yes. Invesco holds 109,875 shares of XERS, worth $870,210, as of its Q2 2026 13F filing. It increased the position by 6,581 shares (+6.4%) from Q1 2026. Invesco has held XERS in every 13F on record since Q4 2021, 19 quarterly filings.
Current Value
$870,210
Current Shares
109,875
Total Value Change
+$677,362
Total Shares Change
+42,209
Quarter-by-Quarter History
Other major holders of XERS: BlackRock, Inc., Vanguard Group Inc.